UK NHS reform: Lords move to rein in “powerful” supplier interests
This article was originally published in Clinica
The UK’s Department of Health will be required to implement measures aimed specifically at dealing with potential conflicts of interest in the commissioning of services in the new NHS, according to proposed changes to the Health and Social Care Bill.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.